Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling

M. Hahn, J. P. Bürckert, C. A. Luttenberger, S. Klebow, M. Hess, M. Al-Maarri, M. Vogt, S. Reißig, M. Hallek, A. Wienecke-Baldacchino, T. Buch, C. P. Muller, C. P. Pallasch, F. T. Wunderlich, A. Waisman, N. Hövelmeyer*

*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology